Azmi AS - Search Results

1

Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma.

Aboukameel A, Muqbil I, Senapedis W, Baloglu E, Landesman Y, Shacham S, Kauffman M, Philip PA, Mohammad RM, Azmi AS. Aboukameel A, et al. Among authors: azmi as. Mol Cancer Ther. 2017 Jan;16(1):76-87. doi: 10.1158/1535-7163.MCT-16-0205. Epub 2016 Nov 15. Mol Cancer Ther. 2017. PMID: 28062705 Free PMC article.

2

Prior exposure to restraint stress enhances 7,12-dimethylbenz(a)anthracene (DMBA) induced DNA damage in rats.

Muqbil I, Azmi AS, Banu N. Muqbil I, et al. Among authors: azmi as. FEBS Lett. 2006 Jul 10;580(16):3995-9. doi: 10.1016/j.febslet.2006.06.030. Epub 2006 Jun 21. FEBS Lett. 2006. PMID: 16806193 Free article.

3

Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3' diindolylmethane (DIM).

Azmi AS, Ahmad A, Banerjee S, Rangnekar VM, Mohammad RM, Sarkar FH. Azmi AS, et al. Pharm Res. 2008 Sep;25(9):2117-24. doi: 10.1007/s11095-008-9581-8. Epub 2008 Apr 22. Pharm Res. 2008. PMID: 18427961 Free PMC article.

4

Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy.

Azmi AS, Mohammad RM. Azmi AS, et al. J Cell Physiol. 2009 Jan;218(1):13-21. doi: 10.1002/jcp.21567. J Cell Physiol. 2009. PMID: 18767026 Free PMC article. Review.

5

Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis.

Azmi AS, Wang Z, Burikhanov R, Rangnekar VM, Wang G, Chen J, Wang S, Sarkar FH, Mohammad RM. Azmi AS, et al. Mol Cancer Ther. 2008 Sep;7(9):2884-93. doi: 10.1158/1535-7163.MCT-08-0438. Mol Cancer Ther. 2008. PMID: 18790769 Free PMC article.

6

SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status.

Al-Katib AM, Sun Y, Goustin AS, Azmi AS, Chen B, Aboukameel A, Mohammad RM. Al-Katib AM, et al. Among authors: azmi as. J Hematol Oncol. 2009 Feb 16;2:8. doi: 10.1186/1756-8722-2-8. J Hematol Oncol. 2009. PMID: 19220884 Free PMC article.

7

Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway.

Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, Azmi AS, Ali S, Abbruzzese JL, Gallick GE, Sarkar FH. Wang Z, et al. Among authors: azmi as. Cancer Res. 2009 Mar 15;69(6):2400-7. doi: 10.1158/0008-5472.CAN-08-4312. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276344 Free PMC article.

8

TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway.

Wang Z, Azmi AS, Ahmad A, Banerjee S, Wang S, Sarkar FH, Mohammad RM. Wang Z, et al. Among authors: azmi as. Cancer Res. 2009 Apr 1;69(7):2757-65. doi: 10.1158/0008-5472.CAN-08-3060. Epub 2009 Mar 24. Cancer Res. 2009. PMID: 19318573 Free PMC article.

9

Plumbagin induces cell death through a copper-redox cycle mechanism in human cancer cells.

Nazeem S, Azmi AS, Hanif S, Ahmad A, Mohammad RM, Hadi SM, Kumar KS. Nazeem S, et al. Among authors: azmi as. Mutagenesis. 2009 Sep;24(5):413-8. doi: 10.1093/mutage/gep023. Epub 2009 Jun 7. Mutagenesis. 2009. PMID: 19505895

10

An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals.

Mohammad RM, Wu J, Azmi AS, Aboukameel A, Sosin A, Wu S, Yang D, Wang S, Al-Katib AM. Mohammad RM, et al. Among authors: azmi as. Mol Cancer. 2009 Dec 3;8:115. doi: 10.1186/1476-4598-8-115. Mol Cancer. 2009. PMID: 19958544 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters